The use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases

Details for Australian Patent Application No. 2003245903 (hide)

Owner Novartis AG

Inventors Hughes, Thomas Edward; Holmes, David Grenville

Agent Davies Collison Cave

Pub. Number AU-B-2003245903

PCT Number PCT/EP03/05762

PCT Pub. Number WO2003/101448

Priority 60/385,220 03.06.02 US

Filing date 2 June 2003

Wipo publication date 19 December 2003

Acceptance publication date 30 November 2006

International Classifications

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/401 (2006.01) - Proline

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

25 September 2003 Complete Application Filed

  Priority application(s): 60/385,220 03.06.02 US

12 February 2004 Application Open to Public Inspection

  Published as AU-B-2003245903

30 November 2006 Application Accepted

  Published as AU-B-2003245903

19 April 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003245904-SHUT-OFF ELEMENT

2003245902-APPARATUS AND METHODS FOR PHOTO-ELECTRIC MEASUREMENT